Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Linagliptin | A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Biochemicals. Alternative Names: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; BI 1356; BI 1356BS; ONDERO. Grades: Highly Purified. CAS No. 668270-12-0. Pack Sizes: 10mg, 100mg, 500mg, 1g. Molecular Formula: C25H28N8O2, Form: Supplied as a white to orange. US Biological Life Sciences. |  Worldwide |
| Linagliptin | Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Trajenta; BI-1356-BS; 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione; Ondero; BI-1356; Linagliptin; Tradjenta. Product Category: Inhibitors. Appearance: Solid. CAS No. 668270-12-0. Molecular formula: C25H28N8O2. Mole weight: 472.54. Purity: 95%+. IUPACName: 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione. Canonical SMILES: CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C. Density: 1.39. Product ID: ACM668270120. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Linagliptin | Linagliptin is a highly potent, selective DPP-4 inhibitor with IC 50 of 1 nM. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BI 1356. CAS No. 668270-12-0. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg; 1 g. Product ID: HY-10284. |  |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Synonyms: Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta. Grade: 98%. CAS No. 668270-12-0. Molecular formula: C25H28N8O2. Mole weight: 472.553. |  |
| Linagliptin-[13C,d3] | Linagliptin-[13C,d3] is the isotope labelled analogue of Linagliptin, which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin-13C,d3; Linagliptin-13C-d3; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl-4-13C-4,4,4-d3)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; (R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl-4-13C-4,4,4-d3)-3-methyl-1-((5-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione. Grade: >95%. CAS No. 1398044-43-3. Molecular formula: C24[13C]H25D3N8O2. Mole weight: 476.56. | |
| Linagliptin Acetamide | Linagliptin Acetamide. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(1-(7-(But-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide,N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]acetamide. CAS No. 1803079-49-3. Pack Sizes: 10MG. IUPAC Name: N-[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]acetamide. Molecular formula: C27H30N8O3. Mole weight: 514.58. Catalog: APS1803079493. SMILES: CC#CCn1c(nc2N(C)C(=O)N(Cc3nc(C)c4ccccc4n3)C(=O)c12)N5CCC[C@H](C5)NC(=O)C. Format: Neat. Shipping: Room Temperature. |  |
| Linagliptin Acetamide-d3 | Linagliptin Acetamide-d3 is the isotope labelled analog of Linagliptin Acetamide. Linagliptin Acetamide is an impurity of linagliptin, which is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Biochemicals. Alternative Names: (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide-d3. Grades: Highly Purified. CAS No. 1297274-00-0. Pack Sizes: 1mg, 2.5mg, 5mg. Molecular Formula: C27H27D3N8O3. US Biological Life Sciences. | Worldwide |
| Linagliptin-[d3] | Linagliptin-[d3] is the isotope labelled analogue of a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin-d3; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3. Grade: 95% by HPLC; 95% atom D. CAS No. 1398044-48-8. Molecular formula: C25H25D3N8O2. Mole weight: 475.56. | |
| Linagliptin-[d4] | Linagliptin-[d4] is a labelled form of Linagliptin, a medication used to treat diabetes mellitus type 2. Synonyms: (R)-8-(3-Aminopiperidin-1-yl-2,2,6,6-d4)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 2140263-92-7. Molecular formula: C25H24D4N8O2. Mole weight: 476.58. | |
| Linagliptin impurity 8 | Linagliptin impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1398044-48-8. Molecular formula: C25H25D3N8O2. Mole weight: 475.57. Catalog: APB1398044488. | |
| Linagliptin Impurity F | Linagliptin Impurity F. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide. CAS No. 1673546-62-7. Molecular formula: C27H27F3N8O3. Mole weight: 568.55. Catalog: APB1673546627. | |
| Linagliptin Related Compound A | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine. Grade: 98.0%. CAS No. 666816-98-4. Molecular formula: C10H9BrN4O2. Mole weight: 297.11. | |
| Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin | Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin is an impurity of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Biochemicals. Grades: Highly Purified. CAS No. 1446263-38-2. Pack Sizes: 1mg. Molecular Formula: C25H28N8O2, Molecular Weight: 472.54. US Biological Life Sciences. | Worldwide |
| Hydroxy Methyl Linagliptin | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: (R,E)-8-(3-Aminopiperidin-1-yl)-1-((4-ethylquinazolin-2-yl)methyl)-7-(4-hydroxy-3-methylbut-2-en-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 8-[(3R)-3-Aminopiperidin-1-yl]-7-[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]-3-methyl-1-[(4-ethylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione. Grade: ≥95%. Molecular formula: C27H34N8O3. Mole weight: 518.61. | |
| (S)-Linagliptin tert-Butyl Ester | (S)-Linagliptin tert-Butyl Ester is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Synonyms: [(3S)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamic Acid 1,1-Dimethylethyl Ester. CAS No. 668273-74-3. Molecular formula: C30H36N8O4. Mole weight: 572.66. | |
| 2-(Chloromethyl)-4-methylquinazoline | 2-(Chloromethyl)-4-methylquinazoline is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Synonyms: 2-(Chloromethyl)-4-methylquinazoline; Linagliptin Impurity 44; NSC 48971; Linagliptin 2-Chloromethyl Impurity. Grade: 0.98. CAS No. 109113-72-6. Molecular formula: C10H9ClN2. Mole weight: 192.65. | |
| 7-(But-2-yn-1-yl)-3-methyl-8-((4-methylquinazolin-2-yl)methoxy)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 7-(But-2-yn-1-yl)-3-methyl-8-((4-methylquinazolin-2-yl)methoxy)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Molecular formula: C30H26N8O3. Mole weight: 546.58. | |
| 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Synonyms: Linagliptin Impurity 33; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]. Grade: 95%. CAS No. 2468656-63-3. Molecular formula: C21H21N7O2. Mole weight: 403.45. | |
| 7-(But-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: Linagliptin Impurity H; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-. Grade: ≥95%. CAS No. 1646355-34-1. Molecular formula: C22H23N7O2. Mole weight: 417.46. | |
| 8-[(3R)-3-Amino-1-piperidinyl]-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-1,7-di-2-butyn-1-yl-3,7-dihydro-3-methyl-; 8-[(3R)-3-Amino-1-piperidinyl]-1,7-di(2-butyn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; (R)-8-(3-Aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity). Grade: ≥95%. CAS No. 2749409-37-6. Molecular formula: C19H24N6O2. Mole weight: 368.44. | |
| 8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione | 8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Synonyms: Linagliptin Impurity 45; 3-Methyl-8-bromoxanthine; 8-Bromo-3-methyl-3,7-dihydropurine-2,6-dione; 8-Bromo-3-methylxanthine; Linagliptin 8-Bromo Impurity; 8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione. Grade: ≥95%. CAS No. 93703-24-3. Molecular formula: C6H5BrN4O2. Mole weight: 245.04. | |
| 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine; 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; Linagliptin Impurity A. Grade: 98%. CAS No. 853029-57-9. Molecular formula: C20H17BrN6O2. Mole weight: 453.29. | |
| (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Synonyms: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; Linagliptin Impurity C. Grade: ≥95%. CAS No. 1791405-13-4. Molecular formula: C15H20N6O2. Mole weight: 316.36. | |
Our database is helping our users find suppliers everyday.
